Quarantine officials say they are preparing to speed up the importation of special cases once the effectiveness of 'Remdesivir', which is expected as a cure for Corona 19, is proven.

Kwon Joon-wook, deputy general manager of the Central Defense Countermeasures Headquarters, said in a regular briefing today (2nd), "We are fully prepared and proceeding with a plan to speed up the process of special importation of Remdesibir."

Under the special importation provisions of the Pharmaceutical Affairs Law, it is possible to manufacture and import drugs that have not been approved or notified of domestic items.

Remdesivir is an antiviral drug developed by Gilead Sciences for the treatment of Ebola. Recently, an initial clinical trial in the United States announced that it was effective in treating Corona19.

The U.S. Food and Drug Administration (FDA) today approved emergency use of remedyvir.

First, Kwon said, "U.S. FDA approval for emergency use is not a formal use approval." Corona 19 is only available for the treatment of seriously suspected or confirmed patients.

He emphasized that the results of the trial should be monitored.

Clinical trials related to Lemdesivir are ongoing all over the world, and there are three clinical trials in Korea.

Kwon said, "As a quarantine authority, we will work closely with the relevant authorities and ministries and discuss with experts to arrange the results of the clinical trials of Remdesivir."

"The results of clinical trials are in the domain of experts, and some are questioning statistical significance," he said. "But the current situation, the authoritative US FDA approved the emergency use of Remdesivir." I am aware. "